What do DSOs look for when acquiring a dental practice?

You have seen the letter of intent. Maybe you have written a few. The number on the front page gets all the attention, and the number is almost never the thing that decides the deal. Acquisition teams spend a few days on the production report and several weeks on a much quieter question: after the ink dries and the founding dentist stops answering the phone at seven in the morning, do the patients still come? That question does not appear on a profit and loss statement. It appears in where new patients came from, who they were actually loyal to, and whether a stranger searching for care in that ZIP code can find the practice at all.

What is the acquisition team actually buying when they buy your practice?

On paper, you are buying collections, a chair count, a lease, a hygiene schedule, and a staff roster. In practice you are buying a stream of future appointments that have not been booked yet. Every hour of diligence is an attempt to price that stream honestly.

Two practices can both produce $1.8M with a full schedule and be worth materially different multiples. In one, demand arrives on its own. In the other, demand arrives because of a person who is about to sign a transition agreement and start counting down the months.

Ask the question the way a buyer asks it privately. Of the new patients who walked through the door last quarter, how many would have walked through it if the founder had been on a three-month sabbatical? That group is the defensible portion of the revenue. Everything else is transition risk that you are being asked to pay full price for today.

Across 201,000+ US practices, the pattern holds without much variation. The practices with the most durable new patient flow are the ones a stranger can find, verify, and choose without a personal introduction. Your diligence should measure that directly instead of assuming it comes bundled with the goodwill line.

Why does your production number matter less than where the production comes from?

Production tells you what happened. Source tells you what happens next. When you decompose a target's revenue by origin, you are separating two very different assets that look identical on a bank statement.

The average solo practice leaves $147K in unrealised annual production on the table, and that figure is not a story about clinical capacity. It is a story about demand that existed in the market and went somewhere else. Your acquisition thesis probably includes closing that gap post-close. If you cannot identify why the gap exists, you are underwriting a recovery you have no mechanism to deliver.

Look at the mix. Implant production is growing 8.5% a year at an average case value of $4,500. Cosmetic is growing 6.8% at $3,800. Orthodontics is growing 5.1% at $5,500. These are the categories that carry a practice's margin, and they are also the categories patients research most heavily before they ever pick up a phone.

A target with strong hygiene retention and thin high-value volume is not a mature practice. It is a practice that never got found by the patients who were shopping for the expensive work.

What does a practice's digital presence tell you about revenue durability?

More than the referral log does, and considerably more than the seller believes. A practice's visibility is the closest thing you have to a durability test that does not depend on the seller's memory.

The Dental Index national practice audit found that 70% of practices are effectively invisible to AI search systems, and the average practice scores below 40 out of 100 on AI readiness. Read that as an acquirer rather than as an operator. Seven out of ten targets you evaluate have no functioning demand source other than word of mouth and whatever the founder built personally over two decades.

Word of mouth is a real asset. It is also the asset most tightly bound to the individual who is leaving. When you buy a practice whose new patient flow is entirely relational, you are buying a decaying annuity and calling it goodwill.

Visibility works the other way. A practice that a stranger finds, compares, and selects has demonstrated that its demand exists independently of any one person. That is the property you are paying a multiple for, whether or not anyone in the room names it out loud.

Are the patients loyal to the practice or loyal to the dentist?

This is the question underneath every retention clause you have ever negotiated, and most diligence processes approach it indirectly through attrition modelling. There is a more direct read available.

Patients who arrived through personal referral chose a person. Patients who arrived through search chose a practice: its reviews, its location, its stated areas of focus, its answers to the questions they typed at eleven at night. The second group has no relationship with the founder to lose.

You already know how this plays out. The founder retires, the associates rotate, and the practice discovers that a meaningful share of its patient base was attached to a name on the door rather than to the door. Attrition shows up in year two, quietly, in the recall column before it shows up in production.

When you evaluate a target, separate the active patient base by acquisition channel and look at the ratio. A practice where most patients found their way in without an introduction has built something transferable. A practice where almost nobody did has built something admirable and largely personal. Price them differently, because they are different assets.

What happens to a valuation when new patient flow depends on one person?

It gets restructured. The headline number may stay intact for negotiating reasons, but the shape of the deal changes: longer earnouts, heavier holdbacks, extended clinical commitments, retention thresholds that the seller finds insulting and you find necessary.

You are not being conservative for its own sake. You are pricing a demand source that walks out with the seller. The practices that avoid this treatment are the ones where demand has a mechanical explanation, and mechanics survive a change in ownership.

Consider what complete, well-maintained Google Business Profiles do in the data. They generate 7x more clicks than incomplete ones, and 82% of local dental searches end in a Maps interaction rather than a website visit. That is a demand channel with no personality attached to it. It keeps running the week after the founder's farewell party.

If you are on the sell side, this is the single most useful thing to understand about how you will be valued. Every unit of new patient flow you can attribute to something other than yourself converts risk-adjusted consideration into cash at close. That conversion is worth more than another point of production growth.

Why is AI visibility becoming a real diligence question?

Because that is where the shopping now happens. There are 432,000 AI-assisted dental searches every month, and the patients running them are not browsing. They are asking a system to name three practices near them that handle a specific procedure well.

Only 8% of practices score above 65 on AI readiness. That is a very small group of targets that show up when the question gets asked, and a very large group that does not exist inside the recommendation at all. Your pipeline is mostly made of the second group.

The commercial detail that matters to your model: AI-referred patients book high-value treatment at two to three times the rate of other channels. These are the implant, cosmetic, and orthodontic cases that carry the margin in your consolidated numbers. A target that is invisible to those systems is not merely missing volume. It is missing the specific volume your thesis depends on.

Add the check to your process. Before the LOI, run the target through the questions its patients would actually ask. What comes back tells you whether you are buying demand or buying a demand project.

How do you test whether growth can continue after the transition?

Historic growth is easy to verify and easy to misread. The useful test is whether the growth had a repeatable cause that you can still operate once the seller is gone.

Three questions get you most of the way there. First, did new patient volume grow, or did production per patient grow because fees moved? Second, can the practice describe what it is known for in one sentence that a patient outside the building would recognise? Third, does that description appear anywhere a patient would encounter it before calling?

A target that cannot answer the second question has a positioning gap, and positioning gaps are the reason acquired practices stall at exactly the production level they arrived at. You add capacity, you add hours, you add an associate, and volume does not follow, because nothing about how the practice is discovered has changed.

This is where a functioning demand capture system separates a platform practice from a tuck-in. One of them gives you a growth lever on day one. The other gives you a maintenance obligation with a growth story attached.

What makes a high-value service mix defensible rather than fragile?

Specificity, and evidence of it in places patients look. High-value production concentrated in one clinician who is leaving is fragile by definition. High-value production that arrives because the practice is consistently found and chosen for a particular procedure is defensible.

The economics reward getting this right. Implants at $4,500 growing 8.5% annually, orthodontics at $5,500 growing 5.1%, cosmetic at $3,800 growing 6.8%. Every one of those categories involves a patient who researched before committing, compared at least two options, and made a decision partly on the strength of what they could verify from the outside.

A general practice that quietly does excellent implant work but says nothing recognisable about it competes on price and proximity for those cases. It wins some. It loses the ones where the patient did their homework.

When you evaluate the mix, ask whether the high-value volume is explained by reputation the market can see or by relationships the market cannot. The first is an asset that survives closing. The second is a person, and people retire.

Why do two practices with identical financials receive different offers?

Because the offers are not really being made on the financials. They are being made on your confidence interval around next year's financials, and confidence is built from evidence of durability.

Source: The Dental Index national practice audit · 2026

The difference between those two columns is not clinical quality. Both practices may deliver excellent care. The difference is whether the market can locate the practice without being introduced to it, and that single variable moves how much of your consideration is payable on day one.

What does a weak search presence actually cost at the negotiating table?

It costs you the argument. When you sit across from a buyer and claim the practice has room to grow, the buyer wants evidence that growth is available and capturable. Absent that, your growth story becomes their upside, and buyers do not pay sellers for upside they have to create.

Here is the uncomfortable arithmetic. If your practice sits in the invisible 70% and scores below 40 on readiness, the buyer's model assumes the demand recovery work will be theirs. They will price the practice at its current state and keep the improvement. You did the nineteen years of clinical work. Someone else monetises the visibility gap you never closed.

The reverse is also true and considerably more pleasant. A practice already capturing search demand walks in with the growth case pre-proven. New patient counts, Maps interactions, and high-value case flow all point the same direction, and none of it depends on the seller staying.

This is why sellers who spend eighteen months on visibility before a process consistently negotiate from a stronger position than sellers who spend eighteen months on production alone.

If you are the buyer, what should you screen for before the LOI?

Screen for the things that will still be true in month thirteen. The financial review will happen regardless, and it rarely produces the surprise that damages the deal.

• Discoverability: whether the practice appears when a patient asks an AI system for a recommendation in that market, given only 8% clear the readiness threshold.
• Channel independence: what share of new patients arrived without a personal introduction from the seller.
• Positioning clarity: whether the practice is known for something specific that a patient outside the building could name.
• Reputation depth: whether review volume and recency support the claim, since 82% of local searches resolve inside Maps.
• Team durability: staffing exposure in a market where 33.9% of practices are actively recruiting hygienists.
• Recoverable demand: the size and cause of the unrealised production gap, and whether you have a lever for it.

The dental market is $179.4B with roughly 32% now under group ownership. Consolidation has already taken the obvious targets. The remaining edge sits in identifying which practices have durable demand and which merely have a busy founder, and pricing the difference correctly. You can read more about why this audit exists and what it set out to measure.

Dr. Ellery's second conversation went differently, eleven months later. Nothing about her clinical work had changed. What changed was that patients who had never met her were finding the practice, reading it, and choosing it for implant consultations. Her new patient origin looked like a system rather than a biography. The earnout shrank. The cash at close grew. Whether you are buying or selling, the same variable is doing the work: can this practice be found, understood, and chosen by someone with no prior connection to it? Clear positioning is what makes Google Maps ranking and AI search visibility function at all. Invisible positioning means an invisible practice, no matter how good the dentistry is or how full the schedule looks today.